Chong Kun Dang Pharmaceutical has been granted a patent for novel compounds with HDAC6 inhibitory activity, useful in treating various diseases. The patent includes a specific 1,3,4-oxadiazole derivative compound. GlobalData’s report on Chong Kun Dang Pharmaceutical gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Chong Kun Dang Pharmaceutical, Cancer treatment biomarkers was a key innovation area identified from patents. Chong Kun Dang Pharmaceutical's grant share as of May 2024 was 39%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11958844B2) discloses a novel 1,3,4-oxadiazole derivative compound represented by a specific chemical formula, its optical isomer, or a pharmaceutically acceptable salt. The compound is designed for preventing or treating diseases related to histone deacetylase 6 activity. The patent outlines the structural characteristics of the compound, including the substitution patterns and permissible variations within the molecule.
Furthermore, the patent describes a pharmaceutical composition containing the 1,3,4-oxadiazole derivative compound as an active ingredient for addressing histone deacetylase 6 activity-related diseases. The composition is intended for a wide range of conditions such as infectious diseases, neoplasms, neurological disorders, and circulatory ailments. Additionally, a method for treating or preventing these diseases by administering a therapeutically effective amount of the compound is also detailed in the patent, highlighting the potential therapeutic applications of this novel chemical entity.
To know more about GlobalData’s detailed insights on Chong Kun Dang Pharmaceutical, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
